Growth Metrics

Madrigal Pharmaceuticals (MDGL) Debt Ratio: 2010-2025

Historic Debt Ratio for Madrigal Pharmaceuticals (MDGL) over the last 9 years, with Sep 2025 value amounting to 0.25.

  • Madrigal Pharmaceuticals' Debt Ratio rose 128.58% to 0.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.25, marking a year-over-year increase of 128.58%. This contributed to the annual value of 0.11 for FY2024, which is 37.43% down from last year.
  • Per Madrigal Pharmaceuticals' latest filing, its Debt Ratio stood at 0.25 for Q3 2025, which was up 113.90% from 0.12 recorded in Q2 2025.
  • In the past 5 years, Madrigal Pharmaceuticals' Debt Ratio registered a high of 0.48 during Q3 2023, and its lowest value of 0.11 during Q2 2024.
  • Moreover, its 3-year median value for Debt Ratio was 0.12 (2025), whereas its average is 0.20.
  • As far as peak fluctuations go, Madrigal Pharmaceuticals' Debt Ratio plummeted by 77.37% in 2024, and later spiked by 128.58% in 2025.
  • Madrigal Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.14 in 2022, then surged by 32.62% to 0.18 in 2023, then tumbled by 37.43% to 0.11 in 2024, then skyrocketed by 128.58% to 0.25 in 2025.
  • Its Debt Ratio stands at 0.25 for Q3 2025, versus 0.12 for Q2 2025 and 0.12 for Q1 2025.